These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25096657)

  • 1. Acquired von Willebrand's disease associated with epithelial myoepithelial carcinoma of the parotid salivary gland.
    Chilvers GS; Porter G
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25096657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma.
    Facon T; Caron C; Courtin P; Wurtz A; Deghaye M; Bauters F; Mazurier C; Goudemand J
    Br J Haematol; 1992 Apr; 80(4):488-94. PubMed ID: 1581233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
    Lison S; Dietrich W; Spannagl M
    Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand's disease.
    Hennessy BJ; White B; Byrne M; Smith OP
    Ir J Med Sci; 1998; 167(2):81-5. PubMed ID: 9638020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment.
    Murakawa M; Okamura T; Tsutsumi K; Tanoguchi S; Kamura T; Shibuya T; Harada M; Niho Y
    Acta Haematol; 1992; 87(1-2):83-7. PubMed ID: 1585777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatide-binding assay for von Willebrand factor. Detection of von Willebrand's disease without discrimination of vWD subtypes.
    Favaloro EJ
    Thromb Res; 2000 Apr; 98(2):213-9. PubMed ID: 10713323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies.
    Mannucci PM; Lombardi R; Bader R; Horellou MH; Finazzi G; Besana C; Conard J; Samama M
    Blood; 1984 Sep; 64(3):614-21. PubMed ID: 6432075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand's disease: a concise review.
    Rinder MR; Richard RE; Rinder HM
    Am J Hematol; 1997 Feb; 54(2):139-45. PubMed ID: 9034288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor.
    Alhumood SA; Devine DV; Lawson L; Nantel SH; Carter CJ
    Am J Hematol; 1999 Feb; 60(2):151-7. PubMed ID: 9929110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells.
    Tefferi A; Hanson CA; Kurtin PJ; Katzmann JA; Dalton RJ; Nichols WL
    Br J Haematol; 1997 Mar; 96(4):850-3. PubMed ID: 9074430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
    Frank RD; Kunz D; Wirtz DC
    Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells.
    Richard C; Cuadrado MA; Prieto M; Batlle J; López Fernández MF; Rodriguez Salazar ML; Bello C; Recio M; Santoro T; Gomez Casares MT
    Am J Hematol; 1990 Oct; 35(2):114-7. PubMed ID: 2205095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.
    Fricke WA; Brinkhous KM; Garris JB; Roberts HR
    Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand disease and multiple myeloma: a case report of a breast cancer survivor.
    Jin N; Salahuddin FF; Nesbitt JA
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):890-3. PubMed ID: 24911454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease.
    Dane KE; Lindsley JP; Kickler T; Streiff MB; Moliterno A; Yui J; Naik R; Chaturvedi S
    Blood Adv; 2021 Jul; 5(14):2813-2816. PubMed ID: 34269797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new flow cytometric method for measurement of von Willebrand factor activity.
    Lindahl TL; Fagerberg IH; Larsson A
    Scand J Clin Lab Invest; 2003; 63(3):217-23. PubMed ID: 12817908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand disease.
    Kumar S; Pruthi RK; Nichols WL
    Mayo Clin Proc; 2002 Feb; 77(2):181-7. PubMed ID: 11838652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.
    Mohri H; Ohkubo T
    Acta Haematol; 1987; 78(4):258-64. PubMed ID: 3122493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.